IL122519A0 - Stabilized pharmaceutical compositions comprising a growth hormone and a peptide - Google Patents

Stabilized pharmaceutical compositions comprising a growth hormone and a peptide

Info

Publication number
IL122519A0
IL122519A0 IL12251996A IL12251996A IL122519A0 IL 122519 A0 IL122519 A0 IL 122519A0 IL 12251996 A IL12251996 A IL 12251996A IL 12251996 A IL12251996 A IL 12251996A IL 122519 A0 IL122519 A0 IL 122519A0
Authority
IL
Israel
Prior art keywords
peptide
pharmaceutical compositions
growth hormone
stabilized pharmaceutical
stabilized
Prior art date
Application number
IL12251996A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL122519A0 publication Critical patent/IL122519A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL12251996A 1995-07-12 1996-06-28 Stabilized pharmaceutical compositions comprising a growth hormone and a peptide IL122519A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88195P 1995-07-12 1995-07-12

Publications (1)

Publication Number Publication Date
IL122519A0 true IL122519A0 (en) 1998-06-15

Family

ID=21693419

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12251996A IL122519A0 (en) 1995-07-12 1996-06-28 Stabilized pharmaceutical compositions comprising a growth hormone and a peptide

Country Status (14)

Country Link
EP (1) EP0837690A1 (cs)
JP (1) JPH11510483A (cs)
KR (1) KR19990028908A (cs)
CN (1) CN1190896A (cs)
AU (1) AU699850B2 (cs)
BR (1) BR9609573A (cs)
CA (1) CA2226553A1 (cs)
CZ (1) CZ6198A3 (cs)
HU (1) HUP9802286A3 (cs)
IL (1) IL122519A0 (cs)
NO (1) NO980103D0 (cs)
PL (1) PL324386A1 (cs)
WO (1) WO1997002833A1 (cs)
ZA (1) ZA965367B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100236393B1 (ko) * 1996-02-02 1999-12-15 나까니시 히로유끼 사람성장호르몬을 함유하는 의약제제
US6566329B1 (en) 1999-06-28 2003-05-20 Novo Nordisk A/S Freeze-dried preparation of human growth hormone
WO2002011695A2 (en) 2000-08-07 2002-02-14 Inhale Therapeutic Systems, Inc. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
TW200501987A (en) * 2002-12-11 2005-01-16 Santen Pharmaceutical Co Ltd Ophthalmic solution preservatives
CN103751769B (zh) * 2013-12-25 2015-08-19 楼秀余 一种冻干重组人生长激素胶囊及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
ATE368472T1 (de) * 1991-12-20 2007-08-15 Novo Nordisk As Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
JPH10511964A (ja) * 1995-01-13 1998-11-17 ノボ ノルディスク アクティーゼルスカブ 成長ホルモン及びＸ−Ｌｙｓを含む安定化医薬製剤

Also Published As

Publication number Publication date
EP0837690A1 (en) 1998-04-29
JPH11510483A (ja) 1999-09-14
HUP9802286A3 (en) 1999-06-28
AU6353396A (en) 1997-02-10
CA2226553A1 (en) 1997-01-30
KR19990028908A (ko) 1999-04-15
PL324386A1 (en) 1998-05-25
ZA965367B (en) 1997-01-23
CN1190896A (zh) 1998-08-19
HUP9802286A2 (hu) 1999-02-01
NO980103L (no) 1998-01-09
BR9609573A (pt) 1999-03-02
CZ6198A3 (cs) 1998-06-17
MX9800309A (es) 1998-07-31
AU699850B2 (en) 1998-12-17
NO980103D0 (no) 1998-01-09
WO1997002833A1 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
IL116743A0 (en) Pharmaceutical composition comprising a growth hormone
HUP9802603A3 (en) Lipophilic peptide hormone derivatives
IL122583A0 (en) Stabilized pharmaceutical formulations comprising a growth hormone pre-treated with zinc
IL116923A0 (en) Compounds with growth hormone releasing properties and pharmaceutical compositions containing them
AU6360394A (en) Vasonatrin peptide and analogs thereof
EP0845265A4 (en) PREPARATION FOR MUCUSA BASED ON PEPTIDES WITH PHYSIOLOGICAL ACTIVITY
IL125361A0 (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
ZA983992B (en) Lh-rh peptide analogues their uses and pharmaceutical compositions containing them
AU686962B2 (en) Pharmaceutical preparation containing human growth hormone
PL324485A1 (en) Application of at least one peptide in a cosmetic composition or in preparation of a medicine
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
ZA98438B (en) A method for stabilizing a peptide and a freese-dried pharmaceutical composition comprising a peptide stabilized by the said method
IL101587A0 (en) Biologically active peptide composition and uses therefor
ZA936692B (en) Physiologically active peptide composition
AU7000896A (en) Novel peptide compounds and medicinal compositions thereof
GB9504761D0 (en) Amphiphilic peptide and analogs thereof
IL122519A0 (en) Stabilized pharmaceutical compositions comprising a growth hormone and a peptide
IL110929A0 (en) Multiple branch peptide constructions and pharmaceutical compositions containing them
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
AU2587195A (en) Growth hormone therapy and related methods and pharmaceutical compositions
IL116742A0 (en) Pharmaceutical composition comprising a growth hormone
AU5997196A (en) A stabilized pharmaceutical formulation comprising growth ho rmone and lys-gly-asp-ser
IL116741A0 (en) Pharmaceutical composition comprising a growth hormone
NZ245239A (en) Hemoregulatory peptides and pharmaceutical compositions
NZ268125A (en) Growth hormone pharmaceutical composition